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OBJECTIVES We sought to examine whether distention of the urinary bladder, a physiologic stimulus,
could induce impaired coronary circulation in patients with early atherosclerosis.
BACKGROUND Distention of the urinary bladder reflexively causes an increase in sympathetic activity. The
effect of such distention on the coronary circulation in patients with early atherosclerosis
remains unknown.
METHODS To assess the effect of bladder distention on coronary dynamic forces, epicardial and
microvascular responses were measured with an intracoronary Doppler flow wire in 40
patients with early atherosclerosis (,50% diameter stenosis). Patients were randomized into
two groups according to whether they did not (group 1, n 5 20) or did have (group 2, n 5
20) pretreatment with an alpha1-adrenergic receptor blocker (oral doxazosin, 2 mg). Coronary
flow velocity was monitored by quantitative coronary angiography at baseline, during urinary
bladder distention and after intracoronary nitroglycerin injection.
RESULTS Bladder distention significantly decreased the coronary diameter in the stenotic segments
(p , 0.001), decreased coronary blood flow (p , 0.001) and increased coronary resistance
(p , 0.001), as compared with baseline values, in group 1 patients. In group 2 patients with
bladder distention, the angiographic variables did not show significant changes, as compared
with baseline values. No significant differences were noted between the groups in the
responses of the angiographic variables after nitroglycerin administration.
CONCLUSIONS The present study shows, for the first time, that urinary bladder distention caused
vasoconstriction of coronary conduit and resistance vessels involved mechanisms related to
alpha1 adrenoceptors. Pretreated administration of doxazosin reversed the changes toward
baseline. Vasoconstriction during bladder distention can be relieved after nitroglycerin
administration, suggesting an unchanged responsiveness of vascular smooth muscle cells to
such distention. (J Am Coll Cardiol 2000;36:453–60) © 2000 by the American College of
Cardiology
The occurrence of transient myocardial ischemia in patients
with coronary artery disease during stress is a common
problem and has been thought to reflect adrenergic stimu-
lation, with resultant increases in cardiac oxygen consump-
tion. However, adrenergically mediated paradoxic vasocon-
striction may also be considered as a possible pathogenetic
mechanism in stenotic coronary arteries (1). Other factors,
including mental stress (2), smoking (3), isometric hand-
grip (4), cold-pressor test (5) and supine exercise (6), have
been shown to produce adrenergically mediated coronary
vasoconstriction. Distention of the urinary bladder has been
shown to cause the reflex response of an increase in
sympathetic tone (7,8). Electrophysiologic studies have
demonstrated that stretching of the bladder wall causes an
increase in afferent activity from the pelvic or hypogastric
nerves (9). The sensory neurons of the bladder lie in the
subepithelial plexus and contain large granulated vesicles
typical of the storage sites for neuropeptides (10). The
efferent effects of reflexes caused an increase in sympathetic
and a decrease in vagal fiber activity (11). Although efferent
cardiac nerves are believed to be involved in the reflex
changes in coronary blood flow (CBF) (12,13), no studies
have demonstrated the vasoconstriction reflex of the coro-
nary arteries caused by distention of the urinary bladder.
This report describes clinical studies designed to examine
whether distention of the urinary bladder, a physiologic
stimulus, could induce epicardial and microvascular re-
sponses in patients with early atherosclerosis by a combined
intracoronary Doppler flow and quantitative coronary an-
giography measure.
METHODS
Patients. The study was conducted prospectively. Patients
were eligible for the present study if they had a single
non–flow-limiting stenosis (,50% diameter stenosis) in the
proximal or mid portion of one major coronary artery.
Exclusion criteria included previous myocardial infarction,
unstable angina pectoris, uncontrolled hypertension, ejec-
tion fraction ,55% by catheterization study, valvular heart
disease, diabetes mellitus and echocardiographic left ven-
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tricular mass index .117 g/m2 for men and 104 g/m2 for
women (14). To make the baseline autonomic system of our
study subjects homogeneous, we excluded patients with
autonomic dysfunction based on the autonomic reflex eval-
uation (15). A total of consecutive 40 patients were in-
cluded. Patients were randomized into two groups on the
basis of the use of doxazosin: group 1 (n 5 20) had no
pretreatment; group 2 (n 5 20) had pretreatment with
doxazosin (2 mg). The clinical characteristics of the patients
are given in Table 1. The study was approved by the
Hospital Review Board of National Taiwan University, and
all subjects provided written, informed consent before par-
ticipation. Medications, including calcium channel and
beta-adrenergic blockers, were held for 24 h before the
procedure, except for doxazosin in group 2 patients. Any
patient who had taken nitroglycerin within 4 h of catheter-
ization was excluded from the study.
Study protocol. Catheterization procedures. Diagnostic left
heart catheterization and angiography were performed from
a femoral approach. After completion of the diagnostic
catheterization, intravenous heparin was supplemented to
maintain an activated clotting time of 300 to 350 s, and a 7F
Judkins catheter was advanced to the ostium of the left or
right coronary artery. A 0.014-in. (0.035-cm) Doppler wire
(FloWire, Cardiometrics, Inc, Mountain View, California)
was first introduced, through a standard angioplasty-type
Y-connector attached to the angiographic catheter, into the
proximal coronary artery that had nonobstructive lesions
(,50%): left anterior descending coronary artery (n 5 23),
circumflex artery (n 5 4) and right coronary artery (n 5 13).
The wire tip was positioned such that characteristics and the
stable flow velocity waveform were obtained. Multiple pairs
of perpendicular views (90°) of the left and right coronary
arteries were obtained. The precise angle, skew rotation and
table height of each projection were recorded so that the
projection could be duplicated. Serial hand injections were
performed at baseline, during urinary bladder distention and
after intracoronary nitroglycerin injection. At each interval,
intracoronary Doppler flow was recorded, and then coronary
angiography was performed.
Intervention procedures. All study subjects underwent a
postvoiding residual catheterization to empty the bladder.
An 8F transurethral catheter was used to fill the bladder
with normal saline at room temperature and was then
attached to a water-filled line and pressure transducer,
which was zeroed to atmospheric pressure. This line mea-
sured the intravesical pressure. Aortic blood pressure, heart
rate, coronary angiograms, intravesical pressure and intra-
coronary Doppler velocity were obtained at baseline. Then,
normal saline was installed slowly from two 50-ml syringes
through the catheter while constantly monitoring the intra-
vesical pressure. If the intravesical pressure reached
20 mm Hg or increased such that there was a risk of leakage
into the urethra, normal saline was withdrawn. The pressure
level of 20 mm Hg was chosen because the intravesical
pressures were at least 17 mm Hg in subjects with normal
bladder function during micturition (16). Because the rate
of filling influences the bladder’s ability to accommodate an
increasing volume and test results (17), the filling rate was
controlled at 50 to 100 ml/min. The same measurements
were obtained 5 min after the stable conditions of distention
of the urinary bladder. Then, 200 mg of nitroglycerin was
infused slowly by direct infusion through the catheter into
the ostium of the coronary artery of interest during disten-
tion of the urinary bladder; all measurements were repeated
within 3 min to avoid tachyphylaxis of small vessels for
sympathetic stimulation (18). To examine the mechanism
of the coronary flow response to distention of the urinary
bladder, the patients in group 2 were pretreated with the
selective alpha1 blocker doxazosin (2 mg orally) 4 h before
cardiac catheterization. This dose was selected because
previous studies used the same dose to obtain alpha-
adrenergic blockade (19). There were no complications
related to the study.
Variable measurements. Angiographic measurements. Digi-
tal coronary angiograms were recorded in three orthogonal
projections before and after each procedure. For each lesion,
the view showing the most severe degree of stenosis was
used for analysis (Fig. 1). The minimal lumen diameter and
proximal angiographically normal segment were measured.
Quantitative measurements of coronary artery dimensions
were made using a computer-based edge enhancement
technique (DCI System, Philips, Inc., Best, The Nether-
Abbreviations and Acronyms
APV 5 average peak velocity
CBF 5 coronary blood flow
CSA 5 cross-sectional area
ECG 5 electrocardiogram or electrocardiographic
MLE 5 myocardial lactate extraction
Table 1. Clinical and Angiographic Characteristics of the Two
Groups
Group 1*
(n 5 20)
Group 2†
(n 5 20) p Value
Gender (M/F) 15/5 16/4 NS
Age (yrs) 57 6 9 56 6 7 NS
Risk factor
Hypertension 6 (30%) 8 (40%) NS
Diabetes mellitus 5 (25%) 4 (20%) NS
Smoking 8 (40%) 9 (45%) NS
Total cholesterol (mg/dl) 184 6 32 176 6 42 NS
HDL cholesterol (mg/dl) 48 6 12 53 6 14 NS
LDL cholesterol (mg/dl) 128 6 28 116 6 32 NS
Triglyceride (mg/dl) 163 6 72 182 6 64 NS
Coronary lesions
LAD 12 (60%) 11 (55%) NS
LCx 2 (10%) 2 (10%) NS
RCA 6 (30%) 7 (35%) NS
*Patients without pretreatment. †Patients pretreated with doxazosin.
Data are presented as the mean value 6 SD or number (%) of patients.
F 5 female; HDL 5 high density lipoprotein; LAD 5 left anterior descending
coronary artery; LCx 5 left circumflex coronary artery; LDL 5 low density
lipoprotein; M 5 male; RCA 5 right coronary artery.
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lands), as previously described (20). The Doppler catheter
was positioned ;10 mm proximal to the stenosis, far from
any large branching vessel. To determine the cross-sectional
area (CSA) of the artery, a 5-mm segment was measured
immediately distal to the tip of the Doppler catheter. All
injections and projections throughout a given study were
performed by the same operator (T.M.L.) to minimize
variability in angiographic technique. Three electrocardio-
graphic (ECG) leads were continuously recorded. These
were selected to reflect leads showing ST segment changes
during bladder distention. Ischemic ECG changes were
defined as a horizontal or downsloping ST segment devia-
tion $0.1 mV at 60 ms after the J point in any lead.
Transient ECG changes that were observed shortly after
coronary arteriography were not taken to be positive. Dur-
ing bladder distention, patients were asked to characterize
the nature of their chest pain. The degree of segmental
vasoreactivity to bladder distention and nitroglycerin was
expressed as the absolute vessel diameters and percent
changes. We have had previous experience with quantitative
coronary arteriography (20,21); the intraobserver and inter-
observer variabilities were 0.18 6 0.15 mm (5.7 6 6.2%)
and 0.21 6 0.23 mm (6.7 6 6.8%), respectively.
Lactate measurements. To confirm myocardial ischemic
during urinary bladder distention, selective catheterization
of the coronary sinus was successfully attempted in the last
10 patients (5 in group 1 and 5 in group 2). Simultaneous
samples of the aortic root and coronary sinus at the same
speed were obtained for measurements of lactate contents.
The myocardial lactate extraction (MLE) ratio was calcu-
lated by the following formula: ([LAO 2 LCS]/LAC) 3 100,
where LAO and LCS represent plasma lactate concentrations
in the aortic root and coronary sinus, respectively.
Calculation of volumetric CBF and coronary resistance. The
coronary flow–velocity measurements were obtained with a
Doppler ultrasound 0.014-in. guide wire. Digitized spectral
peak velocity waveforms were averaged to compute the
average peak velocity (APV). The monitor display was
continuously recorded on super VHS videotape for off-line
analysis. Volumetric CBF was calculated as CBF (ml/
min) 5 CSA (mm2) 3 APV (cm/s) 3 0.5 3 0.6, as
validated by Doucette et al. (22). The factor of 0.5 has been
empirically validated and corresponds to the correction for a
parabolic velocity profile by compensating for the ratio of
spectral peak velocity, as measured by the Doppler system,
to the spatial average velocity required for the calculation of
volumetric flow. Coronary resistance was derived as mean
blood pressure divided by CBF.
Statistics. The continuous variables are expressed as the
mean value 6 SD. After testing data for normality, two-way
repeated-measures analysis of variance was used to search
for the possible effects of intracoronary nitroglycerin and
doxazosin on the coronary angiographic measurements. The
interaction term of nitroglycerin and doxazosin effects was
incorporated into the model. In case of a significant effect,
the measurements at each time point were compared, with
Figure 1. Cinearteriogram frames and coronary diameter measurements in
a 65-year-old man with ECG ischemic changes (from group 1 without
pretreatment with an alpha1 blocker). Coronary vasoconstriction was noted
during urinary bladder distention at the stenotic segment (arrowhead),
which was relieved after intracoronary nitroglycerin administration. A,
Baseline. B, During bladder distention with an intravesical pressure of
20 mm Hg. C, After intracoronary injection of nitroglycerin (200 mg) with
an intravesical pressure ;20 mm Hg.
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p , 0.017 (Bonferroni correction) as significant. The
Student unpaired t test was also used to compare the effect
of doxazosin on vascular responses between the two groups.
Chi-square analysis was used for categoric variables, and the
Fisher exact test was used for patient numbers ,5. Proba-
bility values are two-tailed, and p , 0.05 was considered to
be statistically significant.
RESULTS
There were no baseline characteristic differences between
the two groups shown in Table 1. These groups were
comparable in terms of gender, age, lipid profile, heart rate
and blood pressure. Coronary risk factors for coronary artery
disease were evenly distributed among the three groups.
Blood pressure was significantly decreased from 103 6 8 to
91 6 5 mm Hg after the doxazosin dose (p , 0.001) in
group 2. The reduction in blood pressure was compatible
with alpha1 blockade after doxazosin administration. The
baseline MLE ratio was positive and similar in both groups
(18 6 8% in group 1, 22 6 11% in group 2). The MLE
ratio during urinary bladder distention was decreased sig-
nificantly in group 1 patients (2 6 7% vs. baseline p 5 0.05),
but remained unchanged in group 2 (17 6 12% vs. baseline,
p 5 NS). Lactate concentrations returned to below the
aortic level after nitroglycerin administration in group 1,
reflecting regression of myocardial ischemia. During bladder
distention, chest pain occurred in 6 (30%) of 20 patients in
group 1 and 0 in group 2. ST segment depression on the
surface ECG occurred in the same six patients (30%) in
group 1 and 0 in group 2.
Bladder distention and hemodynamic data. The intraves-
ical pressure was similar in the two groups—namely, 20.8 6
1.5 mm Hg in group 1 (range 18 to 23, filling 200 to 530 ml
of normal saline) and 21.2 6 1.4 mm Hg in group 2 (range
17 to 22, filling 225 to 455 ml of normal saline).
An increase in intravesical pressure induced an increase in
heart rate of 9 6 8 beats/min (range 24 to 29; p , 0.001)
from the baseline level of 67 6 7 beats/min (range 56 to 82)
in group 1 (Table 2). Changes in heart rate, mean blood
pressure and rate–pressure product at rest, during bladder
distention and after intracoronary nitroglycerin administra-
tion were also comparable between the two groups.
Epicardial vasomotor response. In group 1, bladder dis-
tention significantly decreased the epicardial coronary di-
ameter by 19 6 6% (from 2.02 6 0.37 to 1.65 6 0.36 mm,
p , 0.001) and decreased CBF by 25 6 17% (from 49.3 6
15.5 to 37.4 6 15.4 ml/min, p , 0.001), as compared with
baseline values (Table 2, Fig. 2) in the stenotic vessel
segments. In contrast to the stenotic segments, the normal
vessel segments had unchanged coronary diameters during
bladder distention. In group 2, there were no significant
changes in the epicardial stenotic coronary diameter and
CBF during bladder distention, as compared with baseline.
There were significant differences of CBF (p 5 0.004)
between the two groups during bladder distention. Ta
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After nitroglycerin administration in the presence of
bladder distention in group 1, in the stenotic vessel seg-
ments, epicardial coronary diameters were significantly in-
creased by 21 6 14%, epicardial coronary CSA by 45 6 34%
and CBF by 40 6 48%, as compared with values during
bladder distention (Table 2). In group 2, the stenotic
epicardial coronary diameter was significantly increased by
9 6 8%, epicardial coronary CSA by 13 6 21% and CBF by
16 6 24% after nitroglycerin administration. No interaction
was noted between the effects of nitroglycerin and doxazosin
on epicardial angiographic variables.
Resistance vessel response. In group 1, bladder distention
significantly increased coronary resistance by 68 6 60%
(p , 0.001), as compared with baseline values (Table 2, Fig.
2). In group 2, there was a trend toward increased coronary
resistance during bladder distention, as compared with
baseline (2.23 6 0.50 vs. 2.00 6 0.55 mm Hg/ml per min,
p 5 0.07). There were significant differences in coronary
resistance (p 5 0.005) between the two groups during
bladder distention.
After nitroglycerin administration in the presence of
bladder distention in group 1, coronary resistance was
decreased by 32 6 23% (p , 0.001), as compared with
values during bladder distention (Table 2), similar to the
changes seen in group 2. There was no interaction between
the effects of nitroglycerin and doxazosin on vascular resis-
tance.
DISCUSSION
The present study demonstrates, for the first time, that
distention of the urinary bladder decreases the coronary
diameter of the stenotic segments and CBF and increases
coronary resistance in a homogeneous group of patients
with similar severities of coronary atherosclerosis. These
angiographic changes resulted in myocardial ischemia, as
assessed by net lactate production. Such changes are not
related to smooth muscle cell alteration because the vaso-
motor response was similar between the two groups after
nitroglycerin administration. Doxazosin administration re-
versed the myocardial ischemia, reflecting the mechanism of
coronary vasoconstriction, and a concomitant increase in
coronary vascular resistance was mediated by alpha1 adre-
noceptors during bladder distention.
Conduit vessels. Our results showing that vasoconstriction
of conduit vessels evoked by urinary bladder distention were
consistent with previous reports showing that sympathetic
activation dilates normal coronary arteries but constricts
atherosclerotic vessels (23). The constriction of coronary
conduit vessels in response to bladder distention may be due
to an exaggerated response to sympathetic activation and, in
part, endothelial function.
Distention of the urinary bladder induces sympathetic
release, which evokes an increase in heart rate, blood
pressure, myocardial oxygen demand and myocardial isch-
Figure 2. The epicardial coronary diameter in the stenotic segments (A), coronary diameter in the normal segments (B), coronary blood flow (C) and
resistance (D) in response to bladder distention and nitroglycerin (NTG) are shown as relative changes from respective baseline values in patients without
pretreatment (open circles) or in those pretreated doxazosin (solid circles). Data are expressed as the mean value 6 SD. Probability values are for the
significance of the two groups with respect to coronary dynamic data during bladder distention and response to nitroglycerin.
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emia, as assessed by sinus lactate production. Distention of
hallow viscera has been shown to stimulate receptors located
in their walls (8,24), which may reflexively affect the
coronary circulation. For instance, distention of the stomach
has been reported to elicit reflex increases in heart rate and
blood pressure and has been related to postprandial angina
(25).
The mechanism of coronary vasoconstriction is mediated
by alpha1 adrenoceptors. Epicardial coronary arteries are
innervated with sympathetic nerve fibers and have alpha1-
and alpha2-adrenergic receptors (26). Baran et al. (26) have
shown that alpha1 receptors are involved in vasoconstriction
of large coronary arteries during exercise. The increased
vascular alpha1 tone can explain epicardial coronary vaso-
constriction during bladder distention. Furthermore, an
alpha1-adrenergic antagonist has been shown in our study to
limit coronary vasoconstriction during bladder distention,
which was consistent with the finding of Collins et al. (27)
that indoramin, a selective alpha1-adrenergic antagonist, has
been shown to limit exercise-induced angina pectoris.
Besides, vasoconstriction of the coronary arteries in re-
sponse to bladder distention could also be caused by
impaired endothelial function. Endothelial dysfunction may
play a central role in precipitating altered vasomotion in the
coronary artery. Hypersensitivity of vascular smooth muscle
in the region of endothelial dysfunction (atherosclerotic
plaque) may produce paradoxic vasoconstriction. Nabel et
al. (28) have demonstrated that sympathetic stimulation
dilates normal and constricts atherosclerotic coronary arter-
ies, which was inconsistent with our finding that vasocon-
striction was noted in stenotic segments but remained
unchanged in “normal reference” segments. However, a
“smooth” appearance of the lumen surface on the coronary
angiogram does not exclude the presence of intimal involve-
ment with atherosclerosis. The presence of functioning
endothelium in normal reference segments may attenuate
urinary bladder distention-induced vasoconstriction.
Increased microvascular resistance. Distention of the uri-
nary bladder causes an increase of coronary vascular resis-
tance in patients with early atherosclerosis. In patients with
coronary disease, coronary resistance increases during sym-
pathetic stimulation because the vasodilatory reserve has
been exhausted such that alpha adrenoceptor–mediated
vasoconstriction is unopposed (29). The failure of CBF to
increase during bladder distention may suggest either endo-
thelial dysfunction or exaggerated sympathetic vasoconstric-
tion at the level of resistance, leading to uncoupling between
increased metabolic demand and coronary flow. Although
atherosclerotic lesions are confined to epicardial vessels, the
functional consequences of atherosclerosis may extend to
the microvessels. The failure of endothelial cells to produce
or release adequate quantities of nitric oxide occurred in
resistance vessels devoid of atheroma.
Effect of nitroglycerin. Nitroglycerin has different effects
on the epicardial and microvascular coronary circulation.
Nitroglycerin causes endothelium-independent epicardial
vasodilation by the formation of exogenous nitric oxide
within vascular smooth muscle cells (30). Nitric oxide will
dilate coronary artery size, even at the segments of impaired
endothelial function (30). Sudhir et al. (31) demonstrated
that nitroglycerin predominantly influences coronary con-
ductance arteries and has large effects on increased CSA,
with minimal effects on coronary resistance, which is not
consistent with our finding that there was a similar effect of
nitroglycerin on conduit (CSA increased by 45%) and
resistance vessels (vascular resistance decreased by 32%). A
possible explanation may be the different doses of nitroglyc-
erin used. Previous reports (32,33) have suggested that large
vessel tone is diminished by low concentrations of nitrates
and small vessels dilate only by higher nitrate concentration.
In fact, the dose of 200 mg of intracoronary nitroglycerin
that we used could dilate resistance vessels (32,33).
Study limitations. This study could be criticized because
heart rate was uncontrolled by cardiac pacing and the
rate–pressure product was not held constant during the
study. Although the patients were not paced during bladder
distention, the degrees of changes in the rate–pressure
product between the two groups were similar. Thus, the
changes in the rate–pressure product could not be a major
factor of vasoconstriction during bladder distention.
Another limitation of the present study was a lack of
normal control data for ethical reasons. The invasive nature
of the study made it impractical to have a normal control
group. Instead, each patient serves as his or her own control.
The third limitation of the present study was the poor
sensitivity of the surface ECG to detect myocardial ischemic
during bladder distention. Sutton et al. (34) reported on the
electrical focus, causing the ST segment changes to be a
localized area of myocardium, and therefore may not be
apparent on the leads of a surface ECG. Besides, the
relatively short bladder distention time may not produce
ischemia sufficient to develop ST-T segment changes. We
did not measure intracoronary ECG and regional wall
motion abnormalities, as assessed by echocardiography,
which has been proved to be more sensitive for detecting
myocardial ischemia (35). Thus, although the supplied flow
was only about one-half of the metabolic flow demand, as
indicated by the decrease of coronary flow (24%) and the
concomitant increase in metabolic demand (32%), as com-
pared to predistention values, only 30% of the patients in
group 1 demonstrated symptoms and signs of ischemia.
The fourth limitation refers to the possibility that the
alpha-adrenergic antagonist used in this study provided an
insufficient dose. However, this is unlikely because the mean
blood pressure reduction after complete blockade of the
alpha-adrenergic pressor effects was 13 mm Hg, as reported
by Guth et al. (36), which is similar to our level of
12 mm Hg.
Finally, although previous studies have used alpha2-
adrenergic blockers to demonstrate the role of adrenergic
receptors in mediating coronary vasoconstriction effects, we
did not use these because they would increase circulating
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norepinephrine and myocardial oxygen consumption (37).
Such adverse myocardial effects will increase the complexity
of effects of alpha2-adrenergic blockers on coronary vaso-
motor function.
Clinical implications. Urinary bladder distention in this
study constitutes a physiologic form of stress and therefore
may have relevance to the clinical setting. During bladder
distention, the reflex coronary vasoconstriction would limit
the expected coronary vasodilation, which is secondary to
the concomitant reflex increases in heart rate and arterial
blood pressure. Traditionally, the relation of bladder disten-
tion to myocardial ischemia has been related to an increased
rate–pressure product, an index of myocardial oxygen de-
mand. From this study, another potentially important con-
tributing mechanism is the reflex coronary vasoconstriction.
Such a vasoconstriction response of resistance vessels distal
the stenosis could further limit the blood supply to the
myocardium and contribute to myocardial ischemia during
bladder distention.
The effects of alpha1 adrenoceptor blockade on the treat-
ment of benign prostatic hyperplasia have been extensively
documented (38). The study suggested that the alpha1 adre-
noceptor blocker is unique among drugs for benign prostatic
hyperplasia in that it has a beneficial effect on CBF during
bladder distention. Particularly, patients with benign prostatic
hyperplasia may coexist with coronary atherosclerosis.
Large volumes of bladder irrigation fluid during trans-
urethral resection of the prostate can produce a complication
known as transurethral resection syndrome. The pathophys-
iologic characteristics are complex, including transient hy-
pervolemia from the absorption of electrolyte-free irrigation
fluid, dilutional hypoalbuminemia, toxicity from glycine and
impaired renal function (39). However, chest pain, with an
incidence of 2% (38) in transurethral resection syndrome,
could not be explained by these mechanisms. The chest pain
during transurethral resection may be explained in part by
the sudden increase in intravesical pressure, which in turn
results in a decrease in CBF (decreased blood supply) and an
increase in the rate–pressure product (increased oxygen
consumption). Thus, the problem may be raised whether it
is necessary to screen for the possibility of coronary artery
disease before performing transurethral resection, especially
in elderly people.
Conclusions. The present study shows that urinary bladder
distention caused a reflex reduction in CBF, even in patients
with early coronary atherosclerosis. The response involved
efferent sympathetic mechanisms related to alpha1 adreno-
ceptors. Pretreatment with doxazosin reversed the decreased
CBF during bladder distention toward baseline. The reflex
reduction in CBF can be relieved after nitroglycerin admin-
istration.
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